This result unveils a possible correlation between the mGluR5 receptor downregulation and the clearance of SOD1 aggregates in ALS, also in line with literature evidence showing that mGluR5 antagonism increases autophagy and prevents disease progression in a Huntington’s disease mouse model [86]. Here, GRM5 is linked to juvenile Huntington disease.